| |
Patient lab values
|
Normal range
|
|---|
| |
At admission
|
After 5 weeks of antiretroviral therapy
| |
|---|
|
Hemoglobin, g/L
|
159
|
117
|
137–180
|
|
White blood cell, ×109/L
|
3.0
|
3.2
|
4.0–11.0
|
|
Platelets, ×109/L
|
50
|
207
|
150–400
|
|
Sodium, mmol/L
|
139
|
139
|
133–145
|
|
Potassium, mmol/L
|
3.4
|
4.0
|
3.3–5.1
|
|
Chloride, mmol/L
|
107
|
108
|
98–111
|
|
Bicarbonate, mmol/L
|
16
|
24
|
21–31
|
|
Creatinine, μmol/L
|
160
|
97
|
50–120
|
|
Total bilirubin, μmol/L
|
20
|
11
|
0–24
|
|
Haptoglobin, g/L
|
1.24
| |
0.30–2.00
|
|
Lactate Dehydrogenase (LDH), U/L
|
1739
|
242
|
100–235
|
|
Ferritin, μg/L
|
69,717
| |
30–400
|
|
D-dimer, mg/L
|
>10
| |
<0.46
|
|
Fibrinogen, g/L
|
2.0
| |
1.6–4.1
|
|
Creatine kinase, U/L
|
25,000
|
232
|
0–195
|
|
Triglycerides, mmol/L
|
4.36
| |
0.60–2.30
|
|
CD4 Count, ×109/L
|
0.137
|
0.275
|
0.499–1.651
|
|
Viral load, copies/mL
|
>7.24 log base 10
|
1.96 log base 10
| |
|
HIV Architect 4th generation assay
|
615.18
|
27.3
|
<1
|
|
Western blot
|
Negative
| |
Negative
|
